Clinical Trial Update: Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 study evaluating the effects of nicotinamide riboside on brain bioenergetics and oxidative stress in individuals with mild cognitive impairment an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Nicotinamide Riboside (nicotinamide riboside)

Snippet

Sponsor: Mclean Hospital | Conditions: Mild Cognitive Impairment, Mild Alzheimer Disease | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING